CMO & Global Therapeutics Lead
Avg Cost/Share
$4.17
Shares
3,908
Total Value
$16,296.36
Owned After
104,945
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hollander David | RVNC | CMO & Global Therapeutics Lead | Nov 18, 2024 | Sell | $4.17 | 3,908 | $16,296.36 | 104,945 |